aluates Reports

$ 0.0

Automative

Intracranial Atherosclerotic Disease Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-25F13672

Global Intracranial Atherosclerotic Disease Treatment Market Research Report 2023

BUY CHAPTERS

Intracranial Atherosclerotic Disease Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25F13672

Report

October 2024

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Stryker

Balt

Terumo

MicroPort

Acandis GmbH

Intracranial Atherosclerotic Disease Treatment - Market Size

The global market for Intracranial Atherosclerotic Disease Treatment was estimated to be worth US$ 841 million in 2023 and is forecast to a readjusted size of US$ 1474 million by 2030 with a CAGR of 8.4% during the forecast period 2024-2030

Intracranial Atherosclerotic Disease Treatment - Market

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intracranial Atherosclerotic Disease Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intracranial Atherosclerotic Disease Treatment by region & country, by Type, and by Application.

The Intracranial Atherosclerotic Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Atherosclerotic Disease Treatment.

Market Segmentation

Scope of Intracranial Atherosclerotic Disease Treatment - Market Report

Report Metric	Details
Report Name	Intracranial Atherosclerotic Disease Treatment - Market
Forecasted market size in 2030	US$ 1474 million
CAGR	8.4%
Forecasted years	2024 - 2030
Segment by Type:	Stent PTA Balloon
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Stryker, Balt, TERUMO, MicroPort, Acandis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intracranial Atherosclerotic Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Intracranial Atherosclerotic Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Intracranial Atherosclerotic Disease Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Intracranial Atherosclerotic Disease Treatment - Market size in 2030?

Ans: The Intracranial Atherosclerotic Disease Treatment - Market size in 2030 will be US$ 1474 million.

Who are the main players in the Intracranial Atherosclerotic Disease Treatment - Market report?

Ans: The main players in the Intracranial Atherosclerotic Disease Treatment - Market are Stryker, Balt, TERUMO, MicroPort, Acandis

What are the Application segmentation covered in the Intracranial Atherosclerotic Disease Treatment - Market report?

Ans: The Applications covered in the Intracranial Atherosclerotic Disease Treatment - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Intracranial Atherosclerotic Disease Treatment - Market report?

Ans: The Types covered in the Intracranial Atherosclerotic Disease Treatment - Market report are Stent, PTA Balloon

Recommended Reports

Stroke Therapy Market

Vascular Intervention Devices

CNS Disorders Drugs

1 Market Overview

1.1 Intracranial Atherosclerotic Disease Treatment Product Introduction

1.2 Global Intracranial Atherosclerotic Disease Treatment Market Size Forecast

1.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Value (2019-2030)

1.2.2 Global Intracranial Atherosclerotic Disease Treatment Sales Volume (2019-2030)

1.2.3 Global Intracranial Atherosclerotic Disease Treatment Sales Price (2019-2030)

1.3 Intracranial Atherosclerotic Disease Treatment Market Trends & Drivers

1.3.1 Intracranial Atherosclerotic Disease Treatment Industry Trends

1.3.2 Intracranial Atherosclerotic Disease Treatment Market Drivers & Opportunity

1.3.3 Intracranial Atherosclerotic Disease Treatment Market Challenges

1.3.4 Intracranial Atherosclerotic Disease Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Intracranial Atherosclerotic Disease Treatment Players Revenue Ranking (2023)

2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Company (2019-2024)

2.3 Global Intracranial Atherosclerotic Disease Treatment Players Sales Volume Ranking (2023)

2.4 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Company Players (2019-2024)

2.5 Global Intracranial Atherosclerotic Disease Treatment Average Price by Company (2019-2024)

2.6 Key Manufacturers Intracranial Atherosclerotic Disease Treatment Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Intracranial Atherosclerotic Disease Treatment Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Intracranial Atherosclerotic Disease Treatment

2.9 Intracranial Atherosclerotic Disease Treatment Market Competitive Analysis

2.9.1 Intracranial Atherosclerotic Disease Treatment Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Intracranial Atherosclerotic Disease Treatment Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Atherosclerotic Disease Treatment as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Stent

3.1.2 PTA Balloon

3.2 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Type

3.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Intracranial Atherosclerotic Disease Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Intracranial Atherosclerotic Disease Treatment Sales Value, by Type (%) (2019-2030)

3.3 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Type

3.3.1 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Intracranial Atherosclerotic Disease Treatment Sales Volume, by Type (2019-2030)

3.3.3 Global Intracranial Atherosclerotic Disease Treatment Sales Volume, by Type (%) (2019-2030)

3.4 Global Intracranial Atherosclerotic Disease Treatment Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Other

4.2 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Application

4.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Intracranial Atherosclerotic Disease Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Intracranial Atherosclerotic Disease Treatment Sales Value, by Application (%) (2019-2030)

4.3 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Application

4.3.1 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Intracranial Atherosclerotic Disease Treatment Sales Volume, by Application (2019-2030)

4.3.3 Global Intracranial Atherosclerotic Disease Treatment Sales Volume, by Application (%) (2019-2030)

4.4 Global Intracranial Atherosclerotic Disease Treatment Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region

5.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region (2019-2024)

5.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region (2025-2030)

5.1.4 Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region (%), (2019-2030)

5.2 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region

5.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (2019-2024)

5.2.3 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (2025-2030)

5.2.4 Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (%), (2019-2030)

5.3 Global Intracranial Atherosclerotic Disease Treatment Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

5.4.2 North America Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

5.5.2 Europe Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

5.6.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

5.7.2 South America Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

5.8.2 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Value

6.2.1 Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.2.2 Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.3.2 United States Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Intracranial Atherosclerotic Disease Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.4.2 Europe Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Intracranial Atherosclerotic Disease Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.5.2 China Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Intracranial Atherosclerotic Disease Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.6.2 Japan Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Intracranial Atherosclerotic Disease Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.7.2 South Korea Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Intracranial Atherosclerotic Disease Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Intracranial Atherosclerotic Disease Treatment Sales Value, 2019-2030

6.9.2 India Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Intracranial Atherosclerotic Disease Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Stryker

7.1.1 Stryker Company Information

7.1.2 Stryker Introduction and Business Overview

7.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Product Offerings

7.1.5 Stryker Recent Development

7.2 Balt

7.2.1 Balt Company Information

7.2.2 Balt Introduction and Business Overview

7.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Balt Intracranial Atherosclerotic Disease Treatment Product Offerings

7.2.5 Balt Recent Development

7.3 TERUMO

7.3.1 TERUMO Company Information

7.3.2 TERUMO Introduction and Business Overview

7.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)

7.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Product Offerings

7.3.5 TERUMO Recent Development

7.4 MicroPort

7.4.1 MicroPort Company Information

7.4.2 MicroPort Introduction and Business Overview

7.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)

7.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Product Offerings

7.4.5 MicroPort Recent Development

7.5 Acandis

7.5.1 Acandis Company Information

7.5.2 Acandis Introduction and Business Overview

7.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Product Offerings

7.5.5 Acandis Recent Development

8 Industry Chain Analysis

8.1 Intracranial Atherosclerotic Disease Treatment Industrial Chain

8.2 Intracranial Atherosclerotic Disease Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Intracranial Atherosclerotic Disease Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Intracranial Atherosclerotic Disease Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Stryker

Balt

Terumo

MicroPort

Acandis GmbH

List of Tables

Table 1. Intracranial Atherosclerotic Disease Treatment Market Trends

Table 2. Intracranial Atherosclerotic Disease Treatment Market Drivers & Opportunity

Table 3. Intracranial Atherosclerotic Disease Treatment Market Challenges

Table 4. Intracranial Atherosclerotic Disease Treatment Market Restraints

Table 5. Global Intracranial Atherosclerotic Disease Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Company (2019-2024)

Table 7. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Intracranial Atherosclerotic Disease Treatment Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Intracranial Atherosclerotic Disease Treatment Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Intracranial Atherosclerotic Disease Treatment Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Intracranial Atherosclerotic Disease Treatment Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Intracranial Atherosclerotic Disease Treatment

Table 13. Global Intracranial Atherosclerotic Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Atherosclerotic Disease Treatment as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Intracranial Atherosclerotic Disease Treatment Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Intracranial Atherosclerotic Disease Treatment Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Intracranial Atherosclerotic Disease Treatment Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Intracranial Atherosclerotic Disease Treatment Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region (2019-2024) & (%)

Table 44. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Region (2025-2030) & (%)

Table 45. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (2019-2024) & (%)

Table 49. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Region (2025-2030) & (%)

Table 50. Global Intracranial Atherosclerotic Disease Treatment Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Intracranial Atherosclerotic Disease Treatment Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Volume, (2025-2030) & (K Units)

Table 57. Stryker Company Information

Table 58. Stryker Introduction and Business Overview

Table 59. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Stryker Intracranial Atherosclerotic Disease Treatment Product Offerings

Table 61. Stryker Recent Development

Table 62. Balt Company Information

Table 63. Balt Introduction and Business Overview

Table 64. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Balt Intracranial Atherosclerotic Disease Treatment Product Offerings

Table 66. Balt Recent Development

Table 67. TERUMO Company Information

Table 68. TERUMO Introduction and Business Overview

Table 69. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. TERUMO Intracranial Atherosclerotic Disease Treatment Product Offerings

Table 71. TERUMO Recent Development

Table 72. MicroPort Company Information

Table 73. MicroPort Introduction and Business Overview

Table 74. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. MicroPort Intracranial Atherosclerotic Disease Treatment Product Offerings

Table 76. MicroPort Recent Development

Table 77. Acandis Company Information

Table 78. Acandis Introduction and Business Overview

Table 79. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Acandis Intracranial Atherosclerotic Disease Treatment Product Offerings

Table 81. Acandis Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. Intracranial Atherosclerotic Disease Treatment Downstream Customers

Table 85. Intracranial Atherosclerotic Disease Treatment Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Intracranial Atherosclerotic Disease Treatment Product Picture

Figure 2. Global Intracranial Atherosclerotic Disease Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Intracranial Atherosclerotic Disease Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Intracranial Atherosclerotic Disease Treatment Sales Volume (2019-2030) & (K Units)

Figure 5. Global Intracranial Atherosclerotic Disease Treatment Sales Price (2019-2030) & (US$/Unit)

Figure 6. Intracranial Atherosclerotic Disease Treatment Report Years Considered

Figure 7. Global Intracranial Atherosclerotic Disease Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Intracranial Atherosclerotic Disease Treatment Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Intracranial Atherosclerotic Disease Treatment Revenue in 2023

Figure 10. Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Stent Picture

Figure 12. PTA Balloon Picture

Figure 13. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Intracranial Atherosclerotic Disease Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Intracranial Atherosclerotic Disease Treatment Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Intracranial Atherosclerotic Disease Treatment Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Clinic

Figure 20. Product Picture of Other

Figure 21. Global Intracranial Atherosclerotic Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Intracranial Atherosclerotic Disease Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Intracranial Atherosclerotic Disease Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Intracranial Atherosclerotic Disease Treatment Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Intracranial Atherosclerotic Disease Treatment Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Intracranial Atherosclerotic Disease Treatment Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Intracranial Atherosclerotic Disease Treatment Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Intracranial Atherosclerotic Disease Treatment Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Intracranial Atherosclerotic Disease Treatment Sales Volume (%), (2019-2030)

Figure 38. United States Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Intracranial Atherosclerotic Disease Treatment Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Intracranial Atherosclerotic Disease Treatment Sales Value by Application (%), 2023 VS 2030

Figure 44. China Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

Figure 46. China Intracranial Atherosclerotic Disease Treatment Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Intracranial Atherosclerotic Disease Treatment Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Intracranial Atherosclerotic Disease Treatment Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Intracranial Atherosclerotic Disease Treatment Sales Value by Application (%), 2023 VS 2030

Figure 56. India Intracranial Atherosclerotic Disease Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Intracranial Atherosclerotic Disease Treatment Sales Value by Type (%), 2023 VS 2030

Figure 58. India Intracranial Atherosclerotic Disease Treatment Sales Value by Application (%), 2023 VS 2030

Figure 59. Intracranial Atherosclerotic Disease Treatment Industrial Chain

Figure 60. Intracranial Atherosclerotic Disease Treatment Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global ICAD Intracranial Atherosclerotic Disease Pathology Market Insights Forecast to 2030

Global Intracranial Aneurysm Treatment Market Insights Forecast to 2030

Global Intracranial Stents Market Research Report 2025

Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Research Report 2024

Intracranial Stent System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Atherosclerosis Therapeutics Market Insights Forecast to 2030

Brain Ischemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Balloon expanded Intracranial Stents Market Research Report 2024

Global Self expandable Intracranial Stents Market Research Report 2024

Global Cerebral Infarction Therapy Market Insights Forecast to 2030

Global Cerebrovascular Disease Market Research Report 2024

Vascular Dementia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intrasaccular Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intracranial Neurosurgery Market Research Report 2025

Global Peripheral Rotational Atherectomy Market Research Report 2024

Global Ischemic Neurointerventional Device Market Research Report 2025

Global Endovascular Rotational Atherectomy Devices Market Research Report 2024

Cerebral Aneurysm Covered Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions